Provigil vs Nuvigil

How they're similar

The similarities are more striking than the differences.

• Same mechanism. Both promote wakefulness through effects on dopamine, norepinephrine, histamine, and orexin systems, though the exact way they work isn't fully mapped. They aren't classical stimulants like amphetamines, and they don't produce the same peripheral effects.
• Same FDA-approved uses. Narcolepsy, obstructive sleep apnea as an adjunct to CPAP or other primary treatment, and shift work sleep disorder.
• Same side effect profile. Headache is by far the most common, then nausea, insomnia, anxiety, dry mouth, and appetite loss. Both share the same rare but serious skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS syndrome, which is why any new rash needs urgent attention.
• Same drug interactions. Both induce CYP3A4, which reduces the effectiveness of hormonal contraceptives, so a backup or alternative form of birth control is needed during use and for a month after stopping. Both inhibit CYP2C19, which can raise levels of some medications like phenytoin, diazepam, and clopidogrel's activation pathway.
• Both are Schedule IV controlled substances in the United States. That reflects a real but modest abuse potential. It's much lower than stimulants like methylphenidate or amphetamines, but not zero.
• Both are available as generics. Brand-name Provigil and Nuvigil still exist, but generic modafinil and generic armodafinil are the usual prescriptions.
• Neither replaces treatment of the underlying cause. In sleep apnea, CPAP is still the treatment, and modafinil or armodafinil are added when residual sleepiness persists despite good CPAP use.

If someone tolerates one, they'll almost certainly tolerate the other. If someone has a bad reaction to one, especially a skin reaction, the other is generally avoided too.

How they differ

The differences are narrow but real. The main one is the shape of how the drug lingers through the day.

The chemistry difference explains most of the rest. Modafinil is a racemic mixture, meaning it contains equal parts of two mirror-image molecules. The R form has a half-life of about 15 hours. The S form has a half-life of only about 4 hours. So a dose of modafinil gives a faster ramp-up in blood levels from the S component, then that piece drops off, and the R component carries the rest of the day.

Armodafinil is only the R form. Blood levels rise more gradually to a peak and then decline more steadily. In practical terms, some people notice armodafinil gives a smoother, longer-feeling wakefulness with less of an early bump. Others don't feel a meaningful difference at all. There isn't strong evidence that one is more effective than the other for any approved use. Head-to-head trials show similar results.

Dosing looks different but the actual milligrams don't translate one-to-one. A common conversion is that 150 mg of armodafinil roughly corresponds to 200 mg of modafinil, and 250 mg armodafinil to 400 mg modafinil. But since armodafinil is only the R form, a smaller number of milligrams delivers a similar amount of the longer-acting component.

Modafinil has been around longer, approved in 1998, while armodafinil came in 2007. Because modafinil has more years of use, it also has more off-label study. Researchers have looked at modafinil for ADHD (mixed results, not FDA-approved for this), cognitive enhancement in healthy people (short-term benefit for some tasks, unclear long-term value), depression as an add-on (modest signal), fatigue in multiple sclerosis, and post-anesthesia sedation. Armodafinil has been studied for some of the same things but less extensively.

Insurance coverage differs and changes over time. Some plans prefer modafinil, some prefer armodafinil, and some cover both with prior authorization for the approved indications. Cash prices for generics vary but are usually in the same range. It's worth checking what your plan covers before starting either.

Side effect tendencies

The side effect list is essentially the same for both.

Headache is the most common side effect for both drugs, showing up in about a third of people in early trials. It often eases after the first week or two, and drinking more water helps for some. Persistent bad headaches are a reason to talk with a prescriber about dose or switching.

Nausea, decreased appetite, dry mouth, and mild jitteriness are all common. Insomnia is common if the dose is taken too late in the day. Both drugs work best taken in the morning for daytime wakefulness, or before a shift for shift work sleep disorder. Taking either one after noon usually disrupts nighttime sleep.

Anxiety and irritability happen for some people. If someone has an anxiety disorder, wakefulness-promoting drugs can make it worse. That's worth a careful weighing before starting.

Heart rate and blood pressure can go up. Both drugs have modest cardiovascular effects, and neither is used in people with a history of significant heart rhythm problems, uncontrolled hypertension, or recent heart attack without careful evaluation. Blood pressure checks during treatment are a reasonable habit.

The rare but serious concerns are the same for both. Severe skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS, are rare but life-threatening. Any new rash, especially with fever or mucosal involvement (mouth, eyes, genitals), means stop the drug and get evaluated urgently. Serious psychiatric events, including mania, psychosis, and suicidal thinking, are uncommon but reported. Angioedema and hypersensitivity reactions can occur.

Both drugs can cause a mild sense of feeling wired, especially at higher doses. That's different from being productive or focused. Some people confuse the two. If the drug is doing its job for wakefulness without adding jitter, that's the target.

What tips the choice

Because these two are so similar, small factors often decide.

Insurance coverage is often the deciding piece. If a plan covers one at a much lower copay, that's usually where treatment starts. Prior authorization is common for both, with documentation of the approved indication.

Duration matters for some people. If someone struggles most with mid-afternoon sleepiness, armodafinil's steadier profile can help. If someone gets rebound wakefulness at night on armodafinil that interferes with sleep, modafinil's earlier taper can work better.

Prior experience carries weight. If a person did well on one and switched only for insurance reasons, going back is reasonable when possible.

Cost varies. Generic modafinil and generic armodafinil are both available, and cash prices depend on the pharmacy. Discount programs sometimes make a big difference.

Off-label use for depression augmentation or fatigue often leans toward modafinil simply because more of the published data uses modafinil. That's not the same as saying modafinil is better for these uses. It's just where the studies happened.

Neither drug is used in pregnancy without careful weighing of risks and benefits. Both carry cautions about contraceptive interactions.

Neither drug replaces good sleep hygiene, CPAP for sleep apnea, or scheduled naps for narcolepsy. They add to those foundations, they don't substitute for them.

Common questions

Is armodafinil stronger than modafinil? Not really. It's more that armodafinil is a cleaner version of one of the two components in modafinil. On a milligram-for-milligram basis, armodafinil delivers more of the longer-acting piece, but head-to-head studies show similar effectiveness. Some people feel armodafinil is smoother or lasts longer through the afternoon. Others feel no difference between the two.

Can I switch between them? Yes, and it's common. There's no cross-taper needed since they work the same way. A prescriber can move from one to the other directly. The dose conversion is rough, with 150 mg armodafinil being close to 200 mg modafinil, and 250 mg armodafinil close to 400 mg modafinil, though individual response varies.

Do these medications work for ADHD? They aren't FDA-approved for ADHD, and the evidence is mixed. Some studies show modest benefit, especially in adults. They aren't standard first-line ADHD treatment, and stimulants like methylphenidate or amphetamines usually work better for core ADHD symptoms. A trial might be reasonable when stimulants aren't tolerated or aren't an option, but it's an off-label decision made with a prescriber.

Will these affect my birth control? Yes. Both induce CYP3A4, which lowers levels of hormonal contraceptives, including pills, patches, rings, and some implants. That reduces effectiveness. A backup method, a non-hormonal method, or a switch in contraceptive approach is needed while on either drug and for at least a month after stopping. This is one of the more important interactions to plan around.

Are these safe long-term? Studies of a year or more of use show reasonable safety, but the long-term data isn't as deep as for older medications. Both are Schedule IV, meaning some abuse potential exists, though it's much lower than classical stimulants. Regular check-ins with a prescriber to reassess whether the drug is still needed, and periodic breaks in some cases, are reasonable. Blood pressure monitoring makes sense during ongoing use.

Sources

This guide draws on current prescribing information and public health references. It is reviewed for clinical accuracy and updated as guidance changes. This is not medical advice.

1. U.S. Food and Drug Administration. Modafinil prescribing information.
2. U.S. Food and Drug Administration. Armodafinil prescribing information.
3. MedlinePlus, U.S. National Library of Medicine.
4. American Academy of Sleep Medicine. Clinical practice guidelines for narcolepsy and shift work disorder.